Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myelomaSuzanne Trudel(University of Toronto), A. Keith Stewart(Princess Margaret Hospital)BloodMarch 2, 200710.1182/blood-2006-10-047951Cited by 217SaveCiteExport RISWatch citationsRelated PapersLongitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression|Nature Communications|2021|30